We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
632 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RITOSA teriparatide 250 microgram/mL solution for injection pre-filled cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TERIPARATIDE SUN teriparatide 250 microgram/mL solution for injection pre-filled cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TERIPARATIDE RBX teriparatide 250 microgram/mL solution for injection pre-filled cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WINLEVI clascoterone 1% w/w cream tube.
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Australian public assessment report (AusPar)Winlevi (clascoterone) has been approved to treat acne vulgaris in patients 12 years of age or older.
-
Australian public assessment report (AusPar)Yonsa Mpred (abiraterone acetate + methylprednisolone) has been approved for the treatment of metastatic castration resistant prostate cancer and metastatic hormone sensitive prostate cancer.